Conduct of Development Clause Samples
Conduct of Development. Gen-Probe, and Chiron in the event it undertakes or is assigned by the Supervisory Board any responsibilities in connection with the Development Program for each such Initial Blood Screening Assay, shall conduct their respective obligations under the Development Program for each Initial Blood Screening Assay in compliance in all material respects with all requirements of applicable laws and regulations and all applicable good laboratory, clinical and manufacturing practices. Gen-Probe and Chiron each shall proceed diligently with their respective obligations under each such Development Program and shall use their respective Commercially Reasonable Efforts to achieve its objectives efficiently and expeditiously. Gen-Probe and Chiron each shall allocate sufficient personnel, equipment, facilities and other resources to each such Development Program to carry out their respective obligations and to accomplish the objectives thereof.
Conduct of Development. During the term of this Agreement, DURA shall use commercially reasonable efforts to (a) conduct the Development on behalf of ▇▇▇▇▇▇ Corp. II in a prudent and skillful manner in accordance, in all material respects, with the annual workplan and budget then in effect and applicable laws, ordinances, rules, regulations, orders, licenses and other requirements now or hereafter in effect and (b) diligently execute such annual workplan and budget and report to ▇▇▇▇▇▇ Corp. II any significant deviations therefrom in a timely manner. ▇▇▇▇▇▇ Corp. II hereby appoints DURA its exclusive agent, for the term of this Agreement, with the sole power and authority to file and prosecute all necessary regulatory applications and permits in DURA's name required to obtain FDA Approval and other regulatory approvals for the ▇▇▇▇▇▇ Products. DURA shall, at ▇▇▇▇▇▇ Corp. II's expense as described below, furnish all labor, supervision, services, supplies and materials necessary to perform the Development in accordance with the annual workplan and budget then in effect. In addition to its undertakings pursuant to the Technology Agreement, DURA agrees to use commercially reasonable efforts, on behalf of itself, DDSI and ▇▇▇▇▇▇ Corp., to attempt to obtain and to sublicense to ▇▇▇▇▇▇ Corp. II subject to the terms and conditions of the Technology Agreement, on behalf of and at the expense of ▇▇▇▇▇▇ Corp. II but in accordance with Section 2.4 of the Technology Agreement, any patent or technology license or sublicense from any Person, including DURA, DDSI or ▇▇▇▇▇▇ Corp., that DURA reasonably determines to be necessary or useful to enable DURA to conduct the Development under this Agreement.
Conduct of Development. Ambit has conducted, or has caused its contractors and consultants to conduct, any and all preclinical and clinical studies related to the CONFIDENTIAL Compounds and Licensed Products in accordance with good laboratory and clinical practice as and where appropriate, and Applicable Law.
Conduct of Development. Gen-Probe shall conduct its obligations under the Development Program for each Initial Clinical Diagnostic Assay in compliance in all material respects with all requirements of applicable laws and regulations and all applicable good laboratory, clinical and manufacturing practices. Gen-Probe shall proceed diligently with its respective obligations under each such Development Program and shall use its Commercially Reasonable Efforts to achieve its objectives efficiently and expeditiously. Gen-Probe shall allocate sufficient personnel, equipment, facilities and other resources to each such Development Program to carry out its obligations and to accomplish the objectives thereof.
Conduct of Development. AND COMMERCIALIZATION OF PRODUCT
Conduct of Development. Each Party shall conduct its Development work in good scientific manner and in compliance with all applicable Laws, including but not limited to cGMP, GLP and GCP, as well as regulations involving investigations of human subject in compliance with expected standards, as applicable.
Conduct of Development. During the term of this Agreement, CVBT shall use commercially reasonable efforts to (a) conduct the Development on behalf of CDCP in a prudent and skillful manner in accordance, in all material respects, with the work plan then in effect and applicable laws, ordinances, rules, regulations, orders, licenses and other requirements now or hereafter in effect and (b) diligently execute such work plan and report to CDCP any significant deviations therefrom in a timely manner. CDCP hereby appoints CVBT its exclusive agent, for the term of this Agreement, with the sole power and authority to file and prosecute all necessary regulatory applications and permits in CVBT’s name required to obtain FDA and other regulatory approvals for CVBT’s Development efforts. Without limiting the generality of the foregoing sentence, absent specific requirements of the FDA to the contrary, CVBT is authorized by CDCP to conduct FDA trials in CVBT’s name. Using the Available Funds provided by CDCP, CVBT shall furnish all labor, supervision, services, supplies and materials necessary to perform the Development in accordance with the work plan then in effect. In addition, CVBT agrees to use commercially reasonable efforts, on behalf of itself and CDCP, to attempt to obtain and to sublicense any patent or technology license or sublicense from any Person, including CVBT, that CVBT reasonably determines to be necessary or useful to enable CVBT to conduct the Development under this Agreement.
Conduct of Development. Gen-Probe and Chiron each shall conduct its development of each Nonexclusive Future Clinical Diagnostic Assay which it selects for development under Section 4.3.1 above in compliance in all material respects with all requirements of applicable laws and regulations and all applicable good laboratory, clinical and manufacturing practices. Subject to Section 4.3.1(b), each party shall proceed diligently with its obligations under each such Development Program and shall use its Commercially Reasonable Efforts to achieve its objectives efficiently and expeditiously.
Conduct of Development. All Development activities related to MDV3100 and the Initial MDV3100 Product have been conducted in accordance with Applicable Law in all material respects.
Conduct of Development. Each party shall conduct its respective obligations under the Development Program for each Product in compliance in all material respects with all requirements of applicable laws and regulations and all applicable good laboratory, clinical and manufacturing practices. Gen-Probe and Novartis each shall proceed diligently with their respective obligations under each such Development Program and shall use their respective Commercially Reasonable Efforts to achieve its objectives efficiently and expeditiously. Gen-Probe and Novartis each shall allocate sufficient personnel, equipment, facilities and other resources to each such Development Program to carry out their respective obligations and to accomplish the objectives thereof.